// App-Quantinova.ai

: International Differences in Baseline Characteristics and Practice Patterns in Patients with NEWLY Diagnosed Multiple Myeloma Undergoing Upfront Autologous STEM Cell Transplantation

Researchers

Presenter

  • Laurent Garderet

Principal Investigators

  • Linda Koster

  • Anita D'Souza

  • Noel Estrada-Merly

  • Parameswaran Hari

  • Wael Saber

  • Andrew J Cowan

  • Minako Iida

  • Shinichiro Okamoto

  • Hiroyuki Takamatsu

  • Shohei Mizuno

  • Koji Kawamura

  • Yoshihisa Kodera

  • Nada Hamad

  • Bor-Sheng Ko

  • Christopher Liam

  • Kim Wah Ho

  • A Sim Goh

  • S Keat Tan

  • Alaa M. Elhaddad

  • Ali Bazarbachi

  • Qamar Un Nisa Chaudhry

  • Rozan Alfar

  • Mohamed-Amine Bekadja

  • Malek Benakli

  • Cristobal Augusto Frutos Ortiz

  • Eloisa Riva

  • Sebastian Galeano

  • Francisca Bass

  • Hira S Mian

  • Arleigh McCurdy

  • Feng Rong Wang

  • Daniel Neumann

  • Mickey Koh

  • John A Snowden

  • Stefan Schonland

  • Donal P. McLornan

  • Patrick John Hayden

  • Anna Sureda

  • Hildegard T. Greinix

  • Mahmoud Aljurf

  • Yoshiko Atsuta

  • Dietger Niederwieser

Medical Centers

  • Department of Haematology, St Vincent's Hospital Sydney, Australia and St Vincent's Clinical School, Sydney, University of New South Wales, Sydney, Australia

  • EBMT Data Office, Leiden, Netherlands

  • Aichi Medical University School of Medicine, Nagakute-cho, Aichi, JPN

  • Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan

  • EBMT Statistical Unit, Leiden, The Netherlands, Leiden, Netherlands

  • University of Leipzig, Leipzig, Germany

  • Institut Català d'Oncologia, Hospital Duran i Reynals. Institut d'Investigació Biomèdica de Bellvitge (IDIBELL). Universitat de Barcelona, Barcelona, Spain

  • Service Hematologie, Sorbonne Université, Hopital Pitié Salpêtière APHP, Paris, France

  • Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia

  • Department of Haematology, Kings's College Hospital, London, United Kingdom

  • Department of Promotion for Blood and Marrow Transplantation, Aichi Medical University School of Medicine, Nagoya, Japan

  • CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI

  • Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan

  • King Hussein Cancer Center, Amman, Jordan

  • Department of medicine, medical college of Wisconsin, Milwaukee

  • Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Nagakute, Japan

  • Department of Pediatric Oncology and Stem Cell Transplantation Unit, National Cancer Institute, Cairo University, Cairo, Egypt

  • Hospital Ampang, Ampang, Selangor, Malaysia

  • BSBMTCT, Department of Haematology, Sheffield Teaching Hospitals NHS Trust, Sheffield, United Kingdom

  • Department of Hematology, Aichi Medical University School of Medicine, Nagakute, Japan

  • Penang general hospital, Penang, Malaysia

  • Hematology Department, British Hospital, Montevideo, Uruguay

  • Hospital del Salvador, Santiago, Chile

  • Bone Marrow Transplantation Program, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon

  • Hospital Central Del Instituto De Prevision Social, Asuncion, Paraguay

  • School of Entrepreneurial and Innovation Studies, Kanazawa University, Kanazawa, Japan

  • Department of Hematology, Ampang Hospital, Ampang, Malaysia

  • Department of Haematology, St George's Hospital NHS Foundation Trust, London, United Kingdom

  • Medical College of Wisconsin, Milwaukee, WI

  • Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA

  • Division of Hematology, Department of Internal Medicine, Medical University of Graz, Graz, Austria

  • AFBMTC/NIBMT, Rawalpindi, Pakistan

  • Cátedra de Hematología, Hospital de Clínicas, Facultad de Medicina, Montevideo, Montevideo, Uruguay

  • Peking University, Beijing, China

  • Department of Hematology and Cell Therapy, EHU st Novembre Bir el Djir Usto, University Ahmed Benbella , Oran, Algeria

  • Department of Internal Medicine V, Amyloidosis Center, Heidelberg University Hospital, Heidelberg, Germany

  • Department of Medicine, Division of Hematology, The Ottawa Hospital, Ottawa, Canada

  • National Taiwan University Hospital, Taipei, Taiwan

  • Centre Pierre et Marie Curie (CPMC), Algiers, Algeria

  • Department of Oncology, McMaster University, Hamilton, Canada

  • Department of Haematology, Trinity College Dublin, St. James's Hospital, Dublin , Ireland

Locations

  • Australia

  • Pakistan

  • Uruguay

  • United States

  • Netherlands

  • Chile

  • Japan

  • China

  • Lebanon

  • Jordan

  • Algeria

  • Paraguay

  • Germany

  • Canada

  • Malaysia

  • Egypt

  • Spain

  • Taiwan

  • United Kingdom

  • France

  • Saudi Arabia

  • Ireland

  • Austria

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Multiple Myeloma

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A